Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.
The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.
The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...
The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...
The Western Journal on MSN4d
Five-Year-Old Boy Dies at Medical Facility When Treatment Device ExplodesA 5-year-old Michigan boy who was being treated in a hyperbaric oxygen chamber died Friday when the chamber exploded. The incident took place at the Oxford Center in Troy, Michigan, shortly before 8 a ...
New research uncovers how declining protein clearance mechanisms with age lead to Alzheimer’s, Parkinson’s, and other ...
AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...
Inhibikase Therapeutics is pausing work on its experimental Parkinson’s disease drug risvodetinib and seeking “strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback